PCAT19: Its Role in Cancer and Pain
Author Information
Author(s): Hu Haijun, Luo Hongliang, Deng Ziqing
Primary Institution: The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
Hypothesis
PCAT19 is involved in cancer pathogenesis and may serve as a biomarker and therapeutic target.
Conclusion
PCAT19 has diverse roles in various cancers, acting as both an oncogene and a tumor suppressor, and is also implicated in neuropathic pain.
Supporting Evidence
- PCAT19 is upregulated in glioma and laryngocarcinoma, suggesting an oncogenic role.
- PCAT19 is downregulated in breast cancer, indicating a potential tumor suppressor function.
- PCAT19 regulates neuropathic pain through specific molecular pathways.
Takeaway
PCAT19 is a special type of RNA that can help doctors understand and treat different cancers and pain conditions.
Methodology
The review compiles current research on PCAT19's involvement in cancer and pain, analyzing its expression and functional roles across various studies.
Limitations
The review may not cover all studies related to PCAT19, and findings may vary based on cancer type and context.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website